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Comparative proteomics to investigate the in vitro 
antiproliferative effect of dietary polyphenols against 
K562 leukemia cells
[Gıda kaynaklı polifenollerin K562 lösemi hücreleri üzerine in vitro çoğalmayı 
önleyici etkisinin karşılaştırmalı proteomik çalışmalarla incelenmesi]
ABSTRACT
Objective: The lack of success with classical targeted therapies in cancer treatment has forced 
researchers to employ either combined therapies or agents that interfere with multiple pathways.In 
this study, a proteomic evaluation was performed to understand the in vitro antiproliferative effect 
of dietary compounds against leukemia cells in proteome level. Typical human cell models of 
leukemia (i.e., wild K562 cells and multi-drug resistant leukemia cells K562/R) were treated with 
rosemary (Rosmarinus officinalis L.) extracts rich in polyphenols and a comparative proteomic 
study was performed to identify up- or down-regulated proteins by in vitro antiproliferative effect 
of polyphenols.
Methods: The protein fraction from the polyphenol-treated and control K562 and K562/R cells 
were separated through two dimensional polyacrylamide gel electrophoresis (2DE) and their 
proteomic profiles compared by image analysis. The proteins identified to be overexpressed or 
underexpressed in K562 and K562/R cells after the polyphenol treatment were identified by 
MALDI-TOF/TOF MS.
Results: The results in this study were evaluated to understand the mode of action of these dietary 
constituents against leukemia cell proliferation. Dietary polyphenols extracted from rosemary 
bring about the up regulation or down regulation of different proteins on leukemia cells. These 
proteins are related to tumorigenesis, cancer proliferation and antioxidant activity.
Conclusion: Our results revealed that the studied rosemary extract rich in polyphenols induced 
the down regulation of adenine phosphoribosyl transferase and annexin A1 in K562/R cell lines 
and tubulin alpha-1C chain in K562 cell lines. According to the expression proteomics results in 
this study, it could be concluded that the rosemary polyphenols shows in vitro antiproliferative 
activity in K562 and K562/R leukemia cell lines.
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ÖZET
Amaç: Kansere karşı bugüne kadar bilinen tedavi yöntemlerinin eksiklikleri araştırmacıları kom-
bine tedavi yöntemlerine veya birden fazla metabolik yolağı etkileyen ajanlarla tedaviye yönlen-
dirmiştir. Bu çalışmada, proteomik bir yaklaşım sergilenerek gıda kaynaklı bileşiklerin lösemi 
hücrelerine karşı in vitro çoğalmayı önleyici etkisi proteom düzeyinde açıklanmaya çalışılmıştır. 
Lösemi hücre hatları (wild tip (K562) ve çoklu ilaç dirençli (K562/R) lösemi hücre hattı) biberiye-
den (Rosmarinus officinalis L.) elde edilen polifenollerce zengin ekstrelerle muamele edilmiştir. 
Karşılaştırmalı proteomik çalışmalar yapılarak polifenollerin in vitro çoğalmayı önleyici etkisiyle 
düşük veya yüksek miktarda ifade edilen proteinler tanımlanmıştır.
Metod: K562 ve K562/R hücre hatlarının biberiyeden elde edilen polifenollerle işlem görmüş 
grubu ve kontol grubuna ait protein fraksiyonları 2 boyutlu poliakrilamid jel elektroforezle (2DE) 
ayrılmış ve proteomik profilleri imaj analiz çalışmaları ile karşılaştırılmıştır. Biberiye ile işlem 
sonrası K562 ve K562/R hücre hatlarında yüksek veya düşük miktarda ifade edildiği tespit edilen 
proteinler belirlenmiş ve MALDI-TOF/TOF MS ile analiz edilerek tanımlanmıştır.
Bulgular: Bu çalışmadan elde edilen sonuçlar, gıda kaynaklı yapı taşlarının lösemi hücrelerinin 
çoğalmasına karşı etki mekanizmasının anlaşılması yönünde değerlendirilmiştir. Biberiyeden elde 
edilen ekstrelerdeki polifenoller lösemi hücre hatlarındaki bazı proteinlerin yüksek veya düşük 
miktarda ifade edilmesine sebebiyet vermektedir ve bu proteinler tümör gelişimi, kanserin yayıl-
ması ve antioksidant aktivite ile ilgili proteinlerdir. 
Sonuç: Elde edilen sonuçlar göstermektedir ki; polifenolce zengin biberiye ekstreleri ile işlem 
görmüş gruplarda K562/R hücre hattı için adenin fosforibosil transferaz ve aneksin A1 düşük 
miktarda ifade edilirken, K562 hücre hattı içinse tübülin alfa-1C düşük miktarda ifade edilmiştir. 
Kıyaslamalı proteomik çalışmalar sonucunda polifenollerce zengin biberiyenin, K562 ve K562/R 
kanser hücrelerinin çoğalmasını önlemede in vitro düzeyde etkili olduğu gösterilmiştir.
Anahtar Kelimeler: “Foodomics”, Proteomik, 2-DE Elektroforez, Lösemi, Biberiye polifenol-
leri, MALDI-TOF
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nols. Moreover, metabolomics analysis indicated that in-
creased glutathione levels in treated-leukemia cells with 
polyphenol-rich extract was linked to the observed anti-
proliferative effect [18]. For a deeper knowledge of the 
molecular mechanisms underlying the antiproliferative 
effect of a rosemary extract rich in phenolic diterpenes 
(mainly, carnosic acid and carnosol), a proteomic study 
was performed in this work. Since proteins are the carrier 
of life activities and the major executors of the functions 
of genes, proteomic studies play also an important role 
in prevention, diagnosis and treatment of cancer [19-21]. 
Direct evaluation of the proteins expressed in tumor cells 
offers information that cannot be obtained by the study 
of DNA alterations or RNA expression pattern. In most 
cases, although studies of differential mRNA expression 
are informative, they do not always correlate with pro-
tein concentrations because the proteome is dynamic and 
keeps changing even in the same cell type at the different 
stages of activity or development. Moreover, proteins are 
often subject to proteolytic cleavage or posttranslational 
modifications that cannot be detected by genome analy-
sis [22-24]. Thus, in the present work, a proteomic study 
was performed, and the effect of rosemary polyphenols 
in two human leukemic cell lines K562 (one showing a 
drug-sensitive phenotype, and another exhibiting a drug-
resistant phenotype), was studied. A combination of two-
dimensional polyacrylamide gel electrophoresis (2DE), 
combined with mass spectrometry (MS), advanced im-
age analysis and bioinformatics-based protein database 
searches, was used for this purpose. 
Materials and Methods
Chemicals and reagents
All chemicals were of analytical reagent grade. Milli-
Q water was from Milli-Q system (Millipore, Bedford, 
MA, USA). Acetone, trichloroacetic acid (TCA) and 
DL-Dithiothreitol (DTT) were from Sigma-Aldrich (St. 
Louis, MO, USA), Merck (Whitehouse Station, NJ, USA) 
and Fluka (Buchs, Switzerland), respectively. Urea and 
3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate (CHAPS) were from Sigma-Aldrich. Bio-Lyte 
3/10 Ampholyte, mineral oil, bromophenol blue used on 
isoelectric focusing were from Bio-Rad (Hercules, CA, 
USA). Glycerol (30% ultrapure) used on preparing equi-
librium buffers was from Bio-Rad. Tributhylphosphine 
(TBP) and iodoacetamide (IAA) from Sigma-Aldrich 
were used as reduction and alkylation agents, respective-
ly. SYPRO® Ruby protein gel stain used for gel staining 
was from Bio-Rad.
Buffers and solutions
Phosphate buffered saline (PBS) solution (138 mM so-
dium chloride, 2.7 mM potassium chloride and 10 mM 
sodium hydrogen phosphate, at pH 7.4) used for cell 
washing and homogenization buffer (10 mM Tris-HCl, 5 
mM EDTA, 120 mM NaCl, at pH 7.4) used in cell dis-
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Introduction
Despite the advances in the understanding of the patho-
physiology of cancer, the current treatment regimens for 
cancer show limited survival chances for most advanced 
stage cancers, since these treatments primarily target tu-
mor bulk but not cancer stem cells [1,2]. In this sense ma-
jor efforts to delay the process of carcinogenesis and to 
reduce the morbidity and mortality of cancer are being 
carried out. All the traditional cancer therapies includ-
ing surgery, hormonal therapy, anti-angiogenesis therapy, 
chemotherapy, immunotherapy, etc. show a lack of ef-
ficacy in long-term outcome because of their failure to 
target cancer stem cells and toxicity due to non-specific 
effects on normal cells [3]. In addition to conventional 
therapeutic drugs, numerous natural dietary constituents 
have shown promising effects in cancer tumor suppres-
sion [4]. On the other hand, a number of epidemiologi-
cal studies have been carried out attempting to correlate 
high dietary phenolic compounds and flavonoid intake, 
through the consumption of fruits and vegetables, with 
reduced risk of cancer [5-8]. The importance of polyphe-
nol intake in reducing the risk of cancer has repeatedly 
been claimed through different dietary interventions [9-
12]. Polyphenols are known to act in signal transduction 
pathways related to cellular proliferation, differentiation, 
apoptosis, inflammation, angiogenesis and metastasis [9].
Mediterranean herb rosemary (Rosmarinus officinalis L.) 
has been associated with a variety of health benefits [13]. 
Among the active constituents of rosemary, phenolic di-
terpenes and triterpenes have been the subject of intense 
research due to their potential benefits for human health 
[14,15]. In addition to their strong antioxidant properties, 
rosemary extracts rich in phenolic diterpenes and triter-
penes have been also of interest for their anti-inflammato-
ry and anticancer activities [15].
Recently, a global concept called Foodomics, based on the 
integration of “omics” approaches, has been introduced 
by our group [16] for a comprehensive evaluation of the 
health benefits of dietary constituents [17]. One of the main 
purposes in this type of studies is to improve our limited 
understanding of the roles of nutritional compounds at the 
different levels of genomic expression (mRNA, protein, 
metabolite). In previous work, we observed that carno-
sol and carnosic acid-enriched extracts from rosemary 
exerted significant antiproliferative activity on human 
leukemia cells [18]. In that work, transcriptomic analysis 
revealed several sets of differentially expressed genes that 
may be involved in relevant biological functions in cancer 
cells. As a representative example, inhibition of myelocy-
tomatosis oncogene (MYC) transcription factor function 
by rosemary polyphenols was found interesting because 
of its importance in cell proliferation. Also, a signifi-
cant transcriptional induction of several antioxidant and 
detoxifying genes (OSGIN1 and NQO1) was involved 
in the response of leukemia cells to rosemary polyphe-
tail containing 4-(2-aminoethyl)benzenesulfonyl fluo-
ride, pepstatin A, E-64, bestatin, leupeptin, and aprotinin 
from Sigma Aldrich. Cells were disrupted with a Poly-
tron® homogenizer Capitol Scientific (Austin, TX, USA) 
and centrifuged for 14 min at 14000 g (at 4ºC). After the 
pellet (nuclear fraction) had been discarded, the super-
natant was centrifuged for 1h at 10000 g (at 4ºC) and 
kept at -80ºC temperature (cytosolic fraction), in which 
the samples could be safely stored without continuing 
enzymatic activity.
Total protein quantification
The total protein amount was determined by using DC 
protein assay from Bio-Rad. Bovine serum albumin 
was used as standard and diluted with homogenization 
buffer-water (50:50, v/v) in a range between 0.2-1.5 mg/
mL, while the collected samples were diluted with water 
(50:50 v/v). Absorbances of standards and samples were 
measured at 750 nm by using PowerWave Microplate 
Spectrophotometer XS (Winooski, VT, USA).
2D-PAGE analysis
Samples (cytosolic fraction) were desalted following a 
protein precipitation procedure using cold (-20ºC) ace-
tone with 10% (v/v) TCA and 20 mM DTT. Protein pellets 
from all samples were solubilized in “sample buffer” to a 
final concentration of 1 mg mL-1. Each 11-cm long IPG 
strip pH 5-8 (Bio-Rad) was rehydrated with 280 μL of 
protein solution for 4 hrs. Isoelectric focusing (IEF) was 
carried out with a Protean IEF Cell (Bio-Rad) using fol-
lowing steps: (i) 1,000 V, 4 hours; (ii) 8,000 V, 2.5 hours; 
(iii) 8,000 V, 50,000 Vh; (iv) 8,000 V–1,000 V, 68000 Vh 
by using a Protean IEF Cell unit from Bio-Rad. After IEF 
process the strips were subjected to a 2-step equilibration 
for 10 minutes (each) by using “equilibration buffer 1” 
and “equilibration buffer 2” under gentle shaking. The 
IPG strips were then laid on a Criterion XT Precast Gel 
4-12% Bis-Tris (IPG 1 Well Comb, 11 cm, 1.0 mm) with 
0.5% agarose in the cathode buffer (Criterion XT MOPS 
Buffer (1x) from Bio-Rad). Precision plus protein un-
stained standard was used as marker on SDS-PAGE. Cri-
terion XT MOPS Buffer (1x) from Bio-Rad was also used 
as running buffer. The electrophoretic run was performed 
by applying a constant voltage of 100 V/gel through a 
PowerPacTM Universal Power Supply from Bio-Rad until 
the dye front reached the bottom of the gel. Gels were in-
cubated in a fixing solution containing 7% acetic acid and 
10% methanol for 48 hours followed by Sypro staining. 
Gels were stained by gentle shaking overnight. After this 
time gels were washed in a washing solution containing 
7% acetic acid and 10% methanol for a few seconds prior 
to image acquisition. The 2-DE gels were scanned with a 
Versa-Doc image system (Bio-Rad). Image analyses were 
performed by using PDQuest 2-D analysis software (ver-
sion 8.0) from Bio-Rad. After filtering the gel images for 
removing the background, spots were automatically de-
tected and manually edited (if necessary). PDQuest 2-D 
ruption process were from Sigma-Aldrich. For protein 
precipitation, 10% TCA and 20 mM DTT in acetone was 
prepared. Sample buffer for solubilization of precipitated 
proteins contains 8 M urea, 2% CHAPS, 50 mM DTT, 
0.2% Bio-Lyte 3/10 ampholyte and 0.001% bromophenol 
blue. Equilibration buffer 1 (375 mM Tris-HCl (pH 8.8), 
6 M urea, 2% SDS and 5 mM TBP) and equilibration buf-
fer 2 (375 mM Tris-HCl (pH 8.8), 6 M urea, 2% SDS and 
135 mM IAA) were used prior to the SDS-PAGE second 
dimension. Agarose solution (containing 0.5% low melt 
agarose, 1x Tris-glycine-SDS buffer, 0.001% bromophe-
nol blue) used to fix the IPG strips at the top of the poly-
acrylamide gels was from Bio-Rad. For SDS-PAGE step, 
Criterion XT MOPS buffer from Bio-Rad was used as 
running electrolyte.
Rosemary extract
Extracts rich in dietary polyphenols were obtained from 
rosemary (Rosmarinus officinalis L.) using supercritical 
fluid extraction (SFE) under the following conditions of 
pressure and solvent: supercritical CO
2
 plus 7% (v/v) 
ethanol at 150 bar and 40ºC for 30 min, as reported pre-
viously [17]. Chemical characterization of this extract 
provided information on the major phenolic constituents, 
namely cirsimaritin, genkwakin, carnosol, carnosic acid 
and methylcarnosate [25].
Cell culture
Human erythroleukemia K562 cell line obtained from 
ATCC (American Type Culture Collection, LGC Pro-
mochem, UK) and a daunomycin (DNM)-resistant 
K562/R cell subline were grown in DMEM supplemented 
with 5% heat-inactivated fetal calf serum, 2 mM of L-
glutamine, 50 U mL-1 of penicillin G and 50 µg mL-1 of 
streptomycin, at 37ºC in humidified atmosphere by apply-
ing 5% CO
2
. Cells were plated at a density of 10000 cells 
cm-2 in 60-mm diameter culture plates. Triplicate samples 
for each leukemia cell line were incubated without rose-
mary polyphenols (control group), and with 5 µM of total 
rosemary polyphenols (treated group), for 48 h.
Cell viability and cell cycle
To verify the previous results on the effect of rosemary 
polyphenols on cell growth [18] cell viability in K562 
and K562/R cell lines was measured by counting total and 
nonviable cells with ADAM Cell Counter (Digital-Bio, 
Korea) technology based on a fluorescent microscopy 
technique with a sensitive CCD camera.
From the cellular distribution pattern of DNA, the induced 
apoptosis by the treatment of the cells with the phenolic 
extract was measured by determining the amount of apop-
totic cells in the sub-G1 peak by flow cytometry in an Ep-
ics XL instrument (Beckman Coulter, Miami, FL, USA).
Sample collection
Control and treated group cells were washed with PBS 
solution. After centrifugation, the pellet was resuspended 
with homogenization buffer and protease inhibitor cock-
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followed by 200 µL ACN. Finally gel plugs were dried 
under a stream of nitrogen. Trypsin (sequencing grade, 
Promega, Madison, WI) at a final concentration of 16 ng 
mL-1 in 25% ACN/50 mM ammonium bicarbonate solu-
tion was added and the digestion took place at 37 ºC for 
6 h. The reaction was stopped by adding 0.5% TFA for 
peptide extraction. The eluted tryptic peptides were dried 
by speed-vacuum centrifugation and were resuspended in 
4 µL of MALDI solution. A 0.8 µL aliquot of each pep-
tide mixture was deposited onto a 386-well OptiTOFTM 
Plate (Applied Biosystems, Framingham, MA, USA) and 
allowed to dry at room temperature. A 0.8 µL aliquot of 
3 mg mL-1 CHCA (α-cyano-4-hydroxycinnamic acid) in 
MALDI solution was then deposited onto the dried digest 
and allowed to dry at room temperature.
Peptide mass fingerprinting
For MALDI-TOF/TOF MS analysis, spectra were auto-
matically acquired on an ABI 4800 MALDI-TOF/TOF 
MS (Applied Biosystems, Framingham, MA, USA) in 
positive ion reflector mode (the ion acceleration voltage 
was 25 kV to MS acquisition and 1 kV to MS/MS) and the 
obtained data were stored into the ABi 4000 Series Ex-
plorer Spot Set Manager. To submit the combined peptide 
mass fingerprinting (PMF) and MS/MS data to MASCOT 
software v.2.2.04 (Matrix Science, London, UK), GPS 
Explorer v4.9 was used, searching in the non-redundant 
NCBI protein database (NCBI no. 20100930 (11,960,556 
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analysis software was also used for comparative analyses 
and selection of the up- or down-regulated proteins after 
polyphenol treatment. Relative comparison of the inten-
sity abundance between control and treated cells was per-
formed using Student’s t-test. Significantly differentially 
expressed protein spots with more than 2-folds increased 
or decreased intensity (p<0.05) as observed in all replicate 
gels were scored were subjected to further analysis.
Two groups were defined in PDQuest software. The first 
group was the proteins statistically identical in the same 
group according to their spot intensities and the second 
group was the proteins having 2-fold between the groups 
(control and treated). The intersection of these two groups 
was the proteins that we focused. Spots with a p-value of 
less than 0.05 and an average change greater than 2-fold 
were considered as statistically significant regulated spots 
and subjected to identification.
In-gel protein digestion
Selected spots were excised manually, deposited in 96-
well plates and processed automatically in a Proteineer 
DP (Bruker Daltonics, Bremen, Germany). Gel spots 
were washed firstly with 200 µL 50 mM ammonium bi-
carbonate and secondly with 200 µL ACN prior to reduc-
tion with 10 mM DTT in 25 mM ammonium bicarbonate 
solution. Alkylation was carried out with 55 mM IAA in 
50 mM ammonium bicarbonate solution. Gel spots were 
then rinsed with 200 µL 50 mM ammonium bicarbonate 
Figure 1. Expression proteomics on K562 and K562/R cancer cell lines treated with polyphenols.
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tively. Treatment with rosemary extract caused several 
changes in protein expression. The overexpressed and 
underexpressed protein spots (with an average change 
greater than 2-fold and a p-value <0.05) after treatment 
with polyphenols were selected and analysed by MALDI-
TOF/TOF MS.
For K562 leukemia cells, 1 protein was underexpressed 
and 17 proteins were overexpressed by the polyphenol 
treatment, while 8 proteins were underexpressed and 5 
proteins were overexpressed after the polyphenol treat-
ment of K562/R leukemia cells (Table 1). The representa-
tive protein patterns of K562 and K562/R cancer cells are 
shown in Figure 3.
The selection for the identification of the overexpressed 
or underexpressed proteins was performed according to 
their fold change values. The mostly changed proteins 
(according to the image analysis results) were identified 
through MALDI-TOF/TOF-MS for K562 and K562/R 
cell lines. The proteins overexpressed or underexpressed 
were manually excised and analysed by MALDI-TOF/
TOF MS. 
Total number of 6 proteins in K562 and 10 proteins in 
sequences; 4,082,908,561 residues)). The confidence in-
terval for protein identification was set to ≥95% (p<0.05) 
and only peptides with an individual ion score above the 
identity threshold were considered as correctly identified.
Results and Discussion
Proteomic analysis
The effect of dietary polyphenols against K562 and 
K562/R cancer cell lines was investigated to elucidate 
the molecular mechanisms that could explain their anti-
proliferative action. The K562 and K562/R cancer cell 
lines treated with rosemary polyphenols were separated 
by 2DE electrophoresis compared with the control groups 
(the same cell lines not-treated) through expression pro-
teomics. For that purpose 2DE for protein separation was 
combined with MS analysis and database search to iden-
tify differentially expressed proteins. Figure 1 shows the 
experimental summary performed in this study.
Protein patterns of control and treated K562 and K562/R 
cells in Sypro-stained gels are given in Figure 2. The PD-
Quest 8.0 program could detect an average of 350 and 347 
resolved spots in K562 and K562/R cancer cells, respec-
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Figure 2. Control and treated cells for K562 and K562/R cell lines.
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TOF-MS results. Their identification is therefore not pro-
vided below.
The identified proteins through peptide mass fingerprint-
ing are shown in Table 2 and Table 3. After protein iden-
tification it was observed that their functions were mainly 
linked to tumorigenesis, cancer proliferation and antioxi-
dant activity. The MS spectra of some of them (Annexin 
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K562/R cancer cell lines were identified through peptide 
mass fingerprinting. However, likely some contamina-
tion took place during the analysis. Namely, spots 4805 
for K562 and spots 4712, 6411 and 7302 for K562/R 
seem to be related to this contamination due to the fact 
that they are not involved in homo sapiens or they are not 
able to be predicted truly according to the MALDI-TOF/
Table 1. The summary of the proteomic study on K562 and K562/R cell lines
Cell Line Total spots  Underexpressed  Overexpressed Identified proteins  Proteins mainly 
 identified proteins proteins through  linked to tumorigenesis, 
 through image 2-fold 2-fold MALDI-TOF/TOF-MS* cancer proliferation 
 analysis p<0.05 p<0.05  and antioxidant activity**
K562 350 1 17 6 5
K562/R 347 8 5 10 7
*Spots ↑4805 for K562 and spots ↑4712, ↓6411 and ↓7302 for K562/R seem to be related with contamination and their identification is therefore not provided 
**Spots ↓3604, ↑3607, ↑4601, ↑5602, and ↑8639 for K562; spots ↓3108, ↓7219, ↓7431, ↑2714, ↑2610, ↑0812, and ↑4611 for K562/R cell lines.
Table 2. Proteins up -or down- regulated in wild leukemic cells (K562) after the polyphenol treatment
 Proteins underexpressed after the treatment
Spot Spot ID IR/IC* Description
1 3604 0.04 Tubulin alpha-6 chain (Alpha-tubulin 6)
  Proteins overexpressed after the treatment
Spot Spot ID IR/IC* Description
2 3607 7.57 60 kDa heat shock protein, mitochondrial [Homo sapiens]
3 4601 5.29 60 kDa heat shock protein, mitochondrial [Homo sapiens]
4 5602 3.58 60 kDa heat shock protein, mitochondrial [Homo sapiens]
5 8639 3.07 D-3-phosphoglycerate dehydrogenase [Homo sapiens]
*Ratio of the intensity of protein spots. IC: control group; IR: treated group.
Table 3. Proteins up -or down- regulated in multi-drug resistant leukemic cells (K562/R) after the 
polyphenol treatment
 Proteins underexpressed after the treatment
Spot Spot ID IR/IC* Description
1 3108 0.29 Adenine phosphoribosyltransferase isoform a
   [Homo sapiens]
2 7219 0.41 Chain A, Crystal Structure Of Hgstp1-1[v104] 
   Complexed With The Gsh Conjugate Of (+)-Anti-Bpde
3 7431 0.49 Annexin A1 [Homo sapiens]
 Proteins overexpressed after the treatment
Spot Spot ID IR/IC* Description
4 2714 6.58 60 kDa heat shock protein, mitochondrial [Homo sapiens]
5 2610 5.28 60 kDa heat shock protein, mitochondrial [Homo sapiens]
6 0812 4.22 78 kDa glucose-regulated protein precursor
   [Homo sapiens]
7 4611 3.02 Retinal dehydrogenase 2 isoform 1 [Homo sapiens]
*Ratio of the intensity of protein spots (IC: control group, IR: treated group)
rine nucleotide salvage pathway. A salvage pathway is a 
pathway in which nucleotides (purine and pyrimidine) are 
synthesized from intermediates in the degradative path-
way for nucleotides [26]. Salvage pathways are used to 
recover bases and nucleosides that are formed during deg-
radation of RNA and DNA [27]. It functions as a catalyst 
in the reaction between adenine and phosphoribosyl pyro-
phosphate to form adenosine monophosphate [27,28]. It 
was observed that adenine phosphoribosyl transferase in 
K562/R cancer cells was down-regulated after the poly-
phenol treatment, which could explain the anti-prolifera-
tive effect of rosemary polyphenols on these cancer cells. 
Retinal dehydrogenase 2 (UniPort ID: O94788) belongs to 
the family of oxidoreductases. Retinal dehydrogenase 2 is 
up-regulated in K562/R cancer cells after the polyphenol 
treatment probably as a result of their pro-antioxidative 
effect. Heat shock proteins (HSP) are overexpressed in a 
wide range of human cancers and are implicated in tumor 
cell proliferation, differentiation, invasion, metastasis, 
death, and recognition by the immune system [29-31]. The 
HSPs could be used either as an anticancer agent alone or 
in combination with tumor antigens, or as target for anti-
chaperone compounds [32]. Since the HSP60 proteins are 
known to be considerably up-regulated on cancer tissues 
in comparison to the normal tissues [33], the up-regulation 
of 60 kDa heat shock proteins (UniPort ID: P10809) in 
both K562 and K562/R cell lines by the rosemary poly-
phenol treatment was looked like an unexpected result in 
first impression. Even though it is well known that HSP60 
expression is increased in leukemia [34], in recent years, 
there are some new knowledge about particularly HSP60 
proteins. As it is indicated, some of the newly identified 
functions of HSP60 are associated with carcinogenesis, 
specifically with tumor cell survival and proliferation. 
A1, Retinal dehydrogenase 2 isoform 1, Tubulin alpha-6 
chain, and D-3-phosphoglycerate dehydrogenase) are 
given in Figure 4. The biological roles of identified pro-
teins are further discussed below.
Adenine phosphoribosyl transferase (UniPort ID: G5E9J2) 
is an enzyme with transferase activity involved in the pu-
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Figure 3. The proteomic pattern of K562 and K562/R cells (spots 
marked as green show proteins overexpressed in treated groups and 
marked as red show underexpressed in polyphenol-treated groups).
Figure 4. MS spectra of annexin A1, retinal dehydrogenase 2 isoform 1, tubulin alpha-6 chain, and D-3-phosphoglycerate dehydrogenase.
Annexin A1 [Homo sapiens]
Mass (m/z) Mass (m/z)
Mass (m/z)Mass (m/z)
Tubulin alpha-6 chain (Alpha-tubulin 6)
Retinal dehydrogenase 2 isoform 1 [Homo sapiens]
D-3-phosphoglycerate dehydrogenase [Homo sapiens]
in human colon carcinoma and indirectly involved in 
promoting cancer progression [47-49]. Suppression of 
D-3-phosphoglycerate dehydrogenase in cell lines with 
elevated D-3-phosphoglycerate dehydrogenase expres-
sion causes a strong decrease in cell proliferation and a 
reduction in serine synthesis [50]. However, it is reported 
that the tamoxifen, an antagonist of the estrogen receptor, 
induces D-3-phosphoglycerate dehydrogenase in breast 
cancer cells [51]. In this study, we also observed the up-
regulation of D-3-phosphoglycerate dehydrogenase after 
the polyphenol treatment of K562 cancer cell lines. This 
remarkable effect after polyphenol treatment will be fur-
ther studied to correlate it with the observed cell prolifera-
tion suppression.
Conclusions
Accumulating evidence has demonstrated the potential 
therapeutic activity of plant polyphenolic compounds in 
human malignancies, including cancer. Moreover, differ-
ent phytochemicals can also synergize with other com-
pounds to produce antiproliferative effects. In this sense, 
new insight on the biological mechanisms involved in 
the antiproliferative properties of dietary constituents in 
cancer cells, has been presented. The present study pro-
vides novel evidence that dietary polyphenols extracted 
from rosemary bring about the up and down regulation of 
different proteins on leukemia cells. These proteins were 
found to be related to tumorigenesis, cancer proliferation 
and antioxidant activity. Our results revealed that the stud-
ied rosemary extract rich in polyphenols induced the down 
regulation of adenine phosphoribosyl transferase and an-
nexin A1 in K562/R cell lines and tubulin alpha-1C chain 
in K562 cell lines. The up-regulation of D-3-phosphoglyc-
erate dehydrogenase after polyphenol treatment of K562 
cancer cell lines was an unexpected result and it could be 
studied further to be correlated with anticancer activity. 
The workflows that have been described in this work are 
a helpful starting point to understand mechanisms of the 
processes involved in antiproliferative activities of rose-
mary polyphenols in cancer in-vitro model. Further work 
is needed to demonstrate the potential benefit of specific 
bioactive components from rosemary, dose-dependent an-
tiproliferative effects, and synergistic or antagonistic ef-
fect of rosemary components in complex extracts.
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